Upifitamab |
| Catalog No.GC70094 |
Upifitamab est un anticorps ADC (anticorps nu upifitamab rilsodotin) utilisé pour la synthèse de molécules d'activité conjuguée d'anticorps (ADC). Upifitamab rilsodotin est un ADC ciblant NaPi2b, utilisé dans la recherche sur le cancer de l'ovaire, en particulier dans les cas de récidive résistante au platine.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2254118-43-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Upifitamab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Upifitamab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *